AVENUE THERAPEUTICS, INC. — Operating Income by Fiscal Year
11 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/31c00e1b-ae5a-4e82-8ee3-fbb178c9d4c2/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-3.1M | 2025-01-01 – 2025-12-31 | evidence 0001437749-26-010359 |
| FY 2024 | $-11.3M | 2024-01-01 – 2024-12-31 | evidence 0001437749-25-010196 |
| FY 2023 | $-14.5M | 2023-01-01 – 2023-12-31 | evidence 0001437749-24-008294 |
| FY 2022 | $-8.0M | 2022-01-01 – 2022-12-31 | evidence 0001410578-23-000557 |
| FY 2021 | $-3.7M | 2021-01-01 – 2021-12-31 | evidence 0001410578-22-000516 |
| FY 2020 | $-5.2M | 2020-01-01 – 2020-12-31 | evidence 0001104659-21-044358 |
| FY 2019 | $-26.3M | 2019-01-01 – 2019-12-31 | evidence 0001104659-20-040345 |
| FY 2018 | $-21.8M | 2018-01-01 – 2018-12-31 | evidence 0001144204-19-013543 |
| FY 2017 | $-11.4M | 2017-01-01 – 2017-12-31 | evidence 0001144204-18-012321 |
| FY 2016 | $-2.4M | 2016-01-01 – 2016-12-31 | evidence 0001144204-18-012321 |
| FY 2015 | $-4.8M | 2015-02-09 – 2015-12-31 | evidence 0001144204-18-012321 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).